Hpv Positive Oropharyngeal Squamous Cell Carcinoma clinical trials

Explore recruiting hpv positive oropharyngeal squamous cell carcinoma clinical trials.

Recruiting hpv positive oropharyngeal squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hpv Positive Oropharyngeal Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, multicentre phase II study of de-escalation of primary chemoradiotherapy of squamous cell carcinoma of oropharynx (OPC) associated with human papilloma virus (HPV)

Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

Hpv Positive Oropharyngeal Squamous Cell Carcinoma trials by city

Hpv Positive Oropharyngeal Squamous Cell Carcinoma clinical trials

Recruiting hpv positive oropharyngeal squamous cell carcinoma studies right now

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Also recruiting in Europe

Prospective, multicentre phase II study of de-escalation of primary chemoradiotherapy of squamous cell carcinoma of oropharynx (OPC) associated with human papilloma virus (HPV)

Hpv Positive Oropharyngeal Squamous Cell Carcinoma trials by city

Other conditions